Proliferation Marker (Ki67) in Sub-Categorization of Neuroendocrine Tumours of the Lung
Objective: The 2015 WHO classification classifies neuroendocrine tumours (NET) of the lung into typical carcinoid, atypical carcinoid, large cell neuroendocrine carcinoma and small cell carcinoma based on morphology alone. Mitosis is the major parameter for this classification, and thus several stud...
Saved in:
Main Authors: | Rashi GARG (Author), Amanjit BAL (Author), Ashim DAS (Author), Navneet SINGH (Author), Harkant SINGH (Author) |
---|---|
Format: | Book |
Published: |
Federation of Turkish Pathology Societies,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MCM3 and Ki67 proliferation markers in odontogenic cysts and ameloblastoma
by: Zohreh Jaafari-Ashkavandi, et al.
Published: (2019) -
Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification
by: Ljudmilla A. G. Nielsen, et al.
Published: (2018) -
Expression of Ki67 and p53 as proliferation and apoptosis markers in adenoid cystic carcinoma
by: Lehadh M Al-Azzawi
Published: (2014) -
Predictive value of morphological features and proliferative markers (mitotic index, Ki-67, PHH3) in bronchopulmonary neuroendocrine tumors
by: L. M. Zakhartseva, et al.
Published: (2021) -
EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence
by: Abdel-Aziz Azza, et al.
Published: (2012)